Individual research recommendation details

Recommendation ID

NG82/2

Question

Organisational models for AMD diagnosis and management:- What is the long-term effectiveness, in terms of patient-relevant outcomes including visual acuity
and quality of life, of different models of care that aim to reduce time from initial presentation to referral, diagnosis and treatment?

Any explanatory notes
(if applicable)

Why this is important:- There is robust evidence showing that visual loss is linked with delays to diagnosis and/or treatment. However, there is a lack of evidence evaluating the impact of any particular model of care/services in reducing any of the time intervals throughout the referral and treatment process, or the subsequent influence of different models of care on peoples' visual acuity and quality of life.
A well-conducted trial would, therefore, provide the evidence base to assess the long-term effectiveness of different organisational models on referral, diagnosis and treatment for people with late AMD (wet active).

Source guidance details

Comes from guidance

Age-related macular degeneration

Number

NG82

Date issued

January 2018

Other details